Dr Jack Bartram is a Consultant Paediatric Haematologist, and the Clinical Director of the Malignancy Diagnostic Service at Great Ormond Street Hospital for Children (GOSH), London, UK. He undertook a PhD at UCL Institute of Child Health, then a leukaemia research fellowship in the Genomic Medicine Programme at The Hospital for Sick Children “SickKids” in Toronto. Dr Bartram leads on molecular diagnostics and has extensive expertise in high throughput sequencing in cancer. His research interest involves using advanced molecular diagnostic techniques to predict outcomes and find targets for novel therapies for children with haematological malignancies, as well as the application of AI to these datasets. Dr Bartram is co-principal investigator on two studies looking at integration of multimodal data in cancer: REVEALL (RElapse-specific therapeutic Vulnerability Evaluation in childhood & young adult Acute Lymphoblastic Leukaemia) study and the SAIL (Scientific Advances in Infant Leukaemia) study. He is currently the Clinical Lead for Haematological Malignancy Genomics in the NHS England North London Genomic Laboratory Hub and has been responsible for the implementation of advanced genomics and whole genome sequencing into clinical practice at GOSH.